Agoviz 25mg tablet

The medication produced Agoviz 25mg tablet by the pharmaceutical company Pharm Evo, containing 25 mg of agomelatine, aimed at treating major depressive disorder and regulating sleep-wake cycles.

Active Substance: Agomelatine (25 mg). Main Function: Used to treat MDD in adults and Agoviz 25mg tablet in pakistan mood symptoms associated with it. Mechanism: Acts as a melatonin receptor agonist (MT1,  MT2) and serotonin receptor antagonist (5-HT 2C) to regulate the synchronisation of the circadian rhythm and brain chemical balance.

Recommended Dosage: 25 mg per day taken orally once daily at bedtime. Increase: May be raised to 50 mg once daily after 2 weeks if there is no clinical response to therapy. Administration: Should be taken as a whole tablet, without crushing or chewing, with water.

Main Adverse Effects: Headache, nausea, fatigue, dizziness, anxiety, insomnia, and somnolence. Liver Tests: May increase the level of liver enzymes; requires liver function tests prior to and during the therapy. Contradictions: Contraindicated for use in patients with liver diseases or impaired liver function and those taking CYP1A2 potent inhibitors (fluvoxamine, ciprofloxacin).

Agoviz 25 mg tablet price in pakistan  comprise the active substance agomelatine and are used mainly for the treatment of MDD in adults.

Depression: Helps to manage major depressive episodes and to prevent their relapse. Sleep Regulating: Helps to synchronise circadian rhythm and corrects the disturbed sleep-wake cycles usually associated with depression. Improved Mood: Helps to improve mood and well-being